185 related articles for article (PubMed ID: 7068669)
1. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
Fasco MJ; Principe LM
J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
[TBL] [Abstract][Full Text] [Related]
2. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
Fasco MJ; Hildebrandt EF; Suttie JW
J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
[TBL] [Abstract][Full Text] [Related]
3. Relationship of dithiothreitol-dependent microsomal vitamin K quinone and vitamin K epoxide reductases inhibition of epoxide reduction by vitamin K quinone.
Preusch PC; Suttie JW
Biochim Biophys Acta; 1984 Mar; 798(1):141-3. PubMed ID: 6704420
[TBL] [Abstract][Full Text] [Related]
4. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.
Thijssen HH; Janssen YP; Vervoort LT
Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):277-80. PubMed ID: 8297331
[TBL] [Abstract][Full Text] [Related]
5. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
Fasco MJ; Principe LM; Walsh WA; Friedman PA
Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
[TBL] [Abstract][Full Text] [Related]
6. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
Preusch PC; Suttie JW
Arch Biochem Biophys; 1984 Nov; 234(2):405-12. PubMed ID: 6497379
[TBL] [Abstract][Full Text] [Related]
7. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
Thijssen HH; Baars LG
Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010
[TBL] [Abstract][Full Text] [Related]
8. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW
Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443
[TBL] [Abstract][Full Text] [Related]
9. Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin.
Thijssen HH
Biochem Pharmacol; 1987 Sep; 36(17):2753-7. PubMed ID: 3632704
[TBL] [Abstract][Full Text] [Related]
10. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
Lee JJ; Principe LM; Fasco MJ
Biochemistry; 1985 Dec; 24(25):7063-70. PubMed ID: 4084561
[TBL] [Abstract][Full Text] [Related]
11. Temporal variation in the effects of warfarin on the vitamin K cycle.
Soulban G; Labrecque G; Bélanger PM
Chronobiol Int; 1990; 7(5-6):403-11. PubMed ID: 2097073
[TBL] [Abstract][Full Text] [Related]
12. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats.
MacNicoll AD
Biochim Biophys Acta; 1985 May; 840(1):13-20. PubMed ID: 3995080
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.
Thijssen HH; Baars LG; Vervoort-Peters HT
Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986
[TBL] [Abstract][Full Text] [Related]
14. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
[TBL] [Abstract][Full Text] [Related]
15. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
Fasco MJ; Preusch PC; Hildebrandt E; Suttie JW
J Biol Chem; 1983 Apr; 258(7):4372-80. PubMed ID: 6833262
[TBL] [Abstract][Full Text] [Related]
16. Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.
Guenthner TM; Cai D; Wallin R
Biochem Pharmacol; 1998 Jan; 55(2):169-75. PubMed ID: 9448739
[TBL] [Abstract][Full Text] [Related]
17. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
de Boer-van den Berg MA; Thijssen HH; Vermeer C
Biochim Biophys Acta; 1986 Oct; 884(1):150-7. PubMed ID: 3490277
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
Hallak HO; Wedlund PJ
Drug Metab Dispos; 1991; 19(1):278-9. PubMed ID: 1673414
[No Abstract] [Full Text] [Related]
19. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
Cain D; Hutson SM; Wallin R
J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
[TBL] [Abstract][Full Text] [Related]
20. The effect of S-warfarin administration on vitamin K 2,3-epoxide reductase activity in liver, kidney and testis of the rat.
Thijssen HH; Janssen CA; Drittij-Reijnders MJ
Biochem Pharmacol; 1986 Oct; 35(19):3277-82. PubMed ID: 3768021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
